Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TP53INP1
REST API REST API
Homo sapiens
TP53INP1 is differentially expressed in 217 experiments: 94 organism parts: mammary gland, cerebellum, ... (92 more);, 83 disease states: normal, Huntington's disease, ... (81 more);, 84 cell types 280 cell lines 40 compound treatments and 54 other conditions.
Synonyms DKFZp434M1317, Teap, P53DINP1, SIP, TP53INP1B, TP53INP1A, FLJ22139
Orthologs TP53INP1 (Gallus gallus)   Trp53inp1 (Mus musculus)   tp53inp1 (Danio rerio)   TP53INP1 (Bos taurus)   Tp53inp1 (Rattus norvegicus)   tp53inp1 (Xenopus laevis)   TP53INP1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term apoptosis, cell cycle arrest, response to stress, induction of apoptosis, nucleus, PML body
UniProt Accession C9JAL6, Q96A56
Search EB-eye ENSG00000164938
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-GEOD-3526, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-4219, E-GEOD-3202, E-GEOD-1657, ... (25 experiments)

Factor Value U/D Experiments
MCF-7
1
2
E-GEOD-20081, E-GEOD-5823, E-GEOD-19639
NCIH226
1
E-MTAB-37
CESS
1
E-MTAB-37
YCC10
1
E-GEOD-15460
BE2C
1
E-MTAB-37
ANBL-6
1
E-MEXP-921
274 more value(s).


Cell type

studied in E-GEOD-22529, E-TABM-40, E-GEOD-20193, E-GEOD-21668, E-MEXP-750, ... (35 experiments)

Factor Value U/D Experiments
memory B cell
2
E-MEXP-2360, E-TABM-702
vascular smooth muscle cell
1
E-TABM-130
spermatocyte
1
E-TABM-130
adipose stem cells derived from adult human donor
1
E-GEOD-20033
CD4 positive T-cell
1
E-GEOD-6338
naive T cell
1
E-GEOD-1460
78 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-22529, E-MEXP-2069, E-MEXP-1121, ... (43 experiments)

Factor Value U/D Experiments
prostate carcinoma
2
E-TABM-26, E-MEXP-2034
gastric carcinoma
2
E-MTAB-37, E-GEOD-15460
DiseaseState
1
E-MEXP-1243
uterine fibroid
1
E-GEOD-7307
teratozoospermia
1
E-GEOD-6872
Fetal Adenoma
1
E-MEXP-2442
77 more value(s).


Compound treatment

studied in E-GEOD-5741, E-GEOD-15205, E-TABM-782, E-TABM-868, E-GEOD-5099, ... (23 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
DMSO
1
E-MEXP-1561
unknown
1
E-GEOD-7307
filtered air
1
E-TABM-127
oligomycin
1
E-MEXP-2285
BCR/FGFR1
1
1
E-GEOD-15811
34 more value(s).


Age years

studied in E-TABM-783

Factor Value U/D Experiments
1
1
E-TABM-783
n/a
1
1
E-TABM-783


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-TABM-325

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-22513, E-GEOD-19246, E-GEOD-21374, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-MEXP-2359, E-MEXP-2283

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-21138, E-GEOD-21887

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, ... (9 experiments)

Genotype
studied in E-TABM-763, E-GEOD-3494, E-GEOD-17476, E-TABM-868, E-TABM-601, ... (10 experiments)

Growth condition
studied in E-MEXP-2657, E-GEOD-12773, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (8 experiments)

Histology
studied in E-TABM-234, E-GEOD-16194, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-TABM-740, E-MEXP-1290, ... (22 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-22056

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-1657, E-GEOD-1460, E-GEOD-4600, ... (6 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246, E-GEOD-20037

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246, E-GEOD-15799, E-GEOD-12198 ... (5 experiments)

Processing time: 0.306 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM